AFT aft pharmaceuticals limited

Ann: WAV/RULE: AFT: AFT Pharmaceuticals Limited (AFT) waiver from Rule 5.2.3

  1. lightbulb Created with Sketch. 2
    • Release Date: 22/12/15 08:35
    • Summary: WAV/RULE: AFT: AFT Pharmaceuticals Limited (AFT) waiver from Rule 5.2.3
    • Price Sensitive: No
    • Download Document  8.81KB
    					AFT
    22/12/2015 08:35
    WAV/RULE
    NOT PRICE SENSITIVE
    REL: 0835 HRS AFT Pharmaceuticals Limited
    
    WAV/RULE: AFT: AFT Pharmaceuticals Limited (AFT) waiver from Rule 5.2.3
    
    NZX Regulation Decision
    AFT Pharmaceuticals Limited (AFT)
    Application for a waiver from NZX Main Board Listing Rule 5.2.3
    
    21 December 2015
    
    Waiver from NZX Main Board Listing Rule 5.2.3
    
    Decision
    
    1. Subject to the conditions set out in paragraph 2 below, and on the basis
    that the information provided by AFT Pharmaceuticals Limited ("AFT") is
    complete and accurate in all material respects, NZX Regulation ("NZXR")
    grants AFT a waiver from Rule 5.2.3 in respect of its ordinary shares for a
    period of twelve months to the extent this Rule requires AFT to have  at
    least 25% of Shares held by Members of the Public holding at least a Minimum
    Holding.
    
    2. The waiver in paragraph 1 above is provided on the conditions that:
    
    a. the AF Trust Escrow Agreement provides that 15% of the Shares held by AF
    Trust must be released from escrow six months after AFT is listed and the
    Escrow Arrangements between AFT and AF Trust and the CRG Funds provide that
    their holdings are released from escrow once AFT's preliminary announcement
    is made for the financial year ending 31 March 2017;
    
    b. NZXR receives an undertaking from the AF Trust that it will not increase
    its holding in AFT during the term of the waiver, otherwise than as a result
    of an allotment pursuant to an offer or issue of shares that is made pro-rata
    to all AFT shareholders;
    
    c. at least 10% of Shares are held by Members of the Public, with each Member
    of the Public holding at least a Minimum Holding;
    d. AFT clearly and prominently discloses this waiver, its conditions, and its
    implications in AFT's half year and annual reports, and in any offer
    documents relating to any offer of Shares undertaken by AFT, during the
    period of the waiver;
    
    e.  AFT makes an announcement to the market on the day of its Listing of the
    results of its Offer, including the number of Members of the Public holding
    at least a Minimum Holding of Shares and the percentage of Shares held by
    Members of the Public holding at least a Minimum Holding;
    
    f. AFT notifies NZXR as soon as practicable if there is any material
    reduction to the total number of Members of the Public holding at least a
    Minimum Holding of Shares, and/or the percentage of Shares held by Members of
    the Public holding at least a Minimum Holding, as announced by AFT on the
    days of its Listing;
    
    g.  AFT consistently monitors the total number of Members of the Public
    holding Shares and the percentage of Shares held by Members of the Public
    holding at least a Minimum Holding; and
    
    h. AFT provides NZXR with a written quarterly update of the total number of
    Members of the Public holding Shares holding at least a Minimum Holding and
    the percentage of Shares held by Members of the Public holding at least a
    Minimum Holding. The quarterly updates are from the date the waiver is
    granted, for the period of the waiver. The updates are to be provided to NZXR
    within ten business days of the end of each quarter.
    
    3. The information on which this decision is based is set out in Appendix One
    to this decision. This waiver will not apply if that information is not or
    ceases to be full and accurate in all material respects.
    
    4. The Rule to which this decision relates is set out in Appendix Two to this
    decision.
    
    5. Capitalised terms that are not defined in the decision have the meanings
    given to them in the Rules.
    
    Reasons
    
    6. In coming to the decision to provide the waiver set out in paragraph 1
    above, NZXR has considered that:
    
    a. the purpose of Rule 5.2.3 is to promote a liquid market which is important
    to ensure efficient price setting and to enable shareholders to trade;
    
    b. AFT expects that on conclusion of the Offer, between 10.5% and 11.8% of
    the Shares will be held by Members of the Public, holding at least a Minimum
    Holding. AFT expects to meet the requirement that 500 Members of the Public
    hold at least a Minimum Holding.  Based on the expected market capitalisation
    of AFT, this will result in at least $26.9 million (represented by not less
    than 9.6 million Shares) being held by Members of the Public, and available
    for trading.  NZXR is satisfied that AFT will maintain a spread of Security
    holders which is sufficient to ensure a liquid market and that the granting
    of this waiver will not adversely affect holders of the Shares;
    
    c. AFT's application for the waiver, and the implications of the waiver, were
    disclosed in the product disclosure statement in respect of the Offer. As
    such, investors under the Offer will have applied for Shares on a fully
    informed basis as to the likely spread of  Shares following quotation
    Further, the condition that AFT announce the results of its Offer, including
    the spread of Shares, will result in a fully informed market;
    
    d. while the Escrow Arrangements will initially reduce the number of Shares
    available for trading, as Shares are released from escrow they will become
    available for sale. The condition contained in paragraph 2(a) above, provides
    NZXR comfort that the AF Trust Escrow Agreement will have the effect that at
    least 25% of the total Shares in AFT are free from escrow and available for
    sale, six months after AFT's Listing. AFT has submitted, and NZXR has no
    reason not to accept, that the spread of Shares is likely to increase over
    time;
    
    e. the conditions in paragraphs 2(d) and (e) above will provide access to
    information about this waiver and its implications for those wishing to trade
    in, or accept any offer of, Shares during the period of this waiver;
    
    f. the conditions contained in paragraphs 2(f), (g) and (h) above require AFT
    to monitor the spread of Shares and to provide information that will allow
    NZXR to monitor any material changes in AFT's spread of Shares over the
    period of the waiver;
    
    g. NZXR will have the opportunity to reconsider the waiver 12 months after
    Listing of AFT, if a waiver is still required. Should the percentage of
    Shares held by Members of the Public holding at least a Minimum Holding drop
    below 10% NZXR will have the opportunity to reconsider this waiver; and
    
    h. there is precedent for this decision.
    
    Appendix One
    
    1. AFT Pharmaceuticals Limited ("AFT") has applied for Listing and Quotation
    of its ordinary shares ("Shares") on the NZX Main Board, following an initial
    public offer by the company (the "Offer").
    
    2. The Offer comprises an offer by AFT of $30.2 million of new Shares plus
    oversubscriptions of up to $4.0 million of new Shares, and a sale by the
    Atkinson Family Trust ("AF Trust") of $3.0 million of existing Shares.
    
    3. The principal shareholders of AFT are the AF Trust and funds managed by
    entities related to CRG, a US-based investment management firm (the "CRG
    Funds"). As at 26 November 2016, AF Trust held 87% of the shares in AFT and
    the CRG Funds held approximately 9% of the shares in AFT, in aggregate.
    
    4. The shares held by the CRG Funds are preferred shares and will convert to
    Shares on completion of the Offer and AFT Listing on the NZX Main Board.
    
    5. On 26 November 2015, the CRG Funds entered into a subscription agreement
    with AFT to subscribe for 5.4 million Shares under a US private placement as
    part of the Offer ("Subscription Agreement"). Accordingly, following
    subscription of these Shares, the CRG Funds will hold between 13.3% to 13.5%
    of the Shares (depending on oversubscriptions).
    
    6. On conclusion of the Offer, the AF Trust will hold between 74.9% and 76.0%
    of the Shares (depending on oversubscriptions).
    
    7. On 26 November 2015, AF Trust and the CRG Funds entered into escrow
    agreements with AFT (together the "Escrow Arrangements").
    
    8. The escrow arrangement entered into by AF Trust provides that:
    
    a. 15% of the Shares held by the AF Trust will be released from escrow six
    months after AFT is Listed; and
    
    b. subject to  a. above, the remaining Shares held by AF Trust will be
    released from escrow, so that they are free to be sold, once AFT's
    preliminary announcement is made for the financial year ending 31 March 2017.
    
    ("AF Trust Escrow Agreement")
    
    9. The escrow agreement with the CRG Funds provides that the Shares held by
    CRG Funds will be released from escrow, so that they are free to be sold,
    once AFT's preliminary announcement is made for the financial year ending 31
    March 2017 ("CRG Escrow Agreement").
    
    Appendix Two
    
    Rule 5.2.3
    
    5.2.3 A Class of Securities will generally not be considered for Quotation on
    the NZSX or NZDX unless those Securities are held by at least 500 Members of
    the Public holding at least 25% of the number of Securities of that Class
    issued, with each Member of the Public holding at least a Minimum Holding,
    and those requirements are maintained, or NZX is otherwise satisfied that the
    Issuer will maintain a spread of Security holders which is sufficient to
    ensure that there is a sufficiently liquid market in the Class of Securities.
    End CA:00275546 For:AFT    Type:WAV/RULE   Time:2015-12-22 08:35:23
    				
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.